相关实验视频
Updated: Mar 12, 2026
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
28.9K
贝纳利祖马布降低了脏ANCA在患有多阳性炎的eosinophilic粒状瘤症的患者
Manali Mukherjee1,2, Nadia Suray Tan1,2, Chynna Huang1
1McMaster University, Hamilton, ON, Canada.
ERJ open research
|March 11, 2026
概括
在EGPA患者中,本拉利祖马布有效降低了自身免疫反应和炎症. 然而,梅波利祖马布在相同的条件下表现出持续或增加的自身免疫活性.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
背景情况:
- 带有多炎的埃索诺菲尔颗粒炎 (EGPA) 是一种罕见的自身免疫性疾病,其特征是埃索诺菲尔炎症和血管炎.
- 目前的治疗方法旨在抑制炎症,但了解生物制剂对潜在自身免疫路径的具体影响至关重要.
研究的目的:
- 为了比较本拉利祖马布和梅波祖马布对EGPA自身免疫标记物和eosinophilic炎症的影响.
- 调查这些生物制剂对特定自身免疫反应的影响,包括抗中性粒细胞体抗体 (ANCA) 和介质素-17A (IL-17A).
主要方法:
- 对EGPA患者进行了回顾性分析,这些患者接受了本拉利祖马布或梅波利祖马布治疗.
- 在治疗开始前和之后评估血清中spanca,IL-17A和eosinophil数量的变化.
主要成果:
- 贝纳利祖马布治疗与spanca和IL-17A水平的显著降低有关,同时减少了eosinophilic炎症.
- 相比之下,接受梅波利祖马布治疗的患者表现出持续或升高的自身免疫标志物水平和持续的eosinophilic活性.
结论:
- 本拉利祖马布在调节关键的自身免疫反应和减少EGPA中的炎症方面表现出有效性.
- 梅波利祖马布可能无法有效抑制EGPA相关的自身免疫活性,这表明这些生物制剂的作用机制不同.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
01:19Antiasthma Drugs: Leukotriene Modifiers
2.1K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.1K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
585
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
585
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.4K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.4K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
688
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
688
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.9K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.9K